Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-020988
Filing Date
2024-08-08
Accepted
2024-08-08 16:30:07
Documents
1
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 form4-08082024_040802.html 4  
1 form4-08082024_040802.xml 4 29638
  Complete submission text file 0001415889-24-020988.txt   31155
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNITED THERAPEUTICS CORP 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
BENKOWITZ MICHAEL (Reporting) CIK: 0001673232 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 241188933